Nocardiosis in Srinagarind Hospital, Thailand: review of 70 cases from 1996–2001  by Mootsikapun, Piroon et al.
Nocardiosis in Srinagarind Hospital, Thailand:
review of 70 cases from 1996—2001
International Journal of Infectious Diseases (2005) 9, 154—158
http://intl.elsevierhealth.com/journals/ijidPiroon Mootsikapun *, Benjamas Intarapoka, Waraporn LiawnorasetDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, ThailandReceived 12 November 2003; received in revised form 31 May 2004; accepted 16 June 2004
Corresponding Editor: Michael Ellis, Al Ain, UAEKEYWORDS
Nocardiosis;
Nocardia;
Opportunistic infection
Summary
Objective: Nocardiosis is a common opportunistic infection found in both immuno-
compromised and immunocompetent patients. The clinical manifestations, under-
lying diseases, radiologic findings, antimicrobial susceptibility and treatment of
nocardial infection are presented here.
Method: A retrospective study at Srinagarind Hospital, Khon Kaen in Thailand was
performed. Medical records from 1996—2001 were reviewed.
Results: There were 81 cases of nocardiosis during the study period but data of only 70
cases were available. 80% of cases were male. The mean age was 39.7 14.9 years.
Underlying diseases were found in 80%, of which HIV infection was the most common
(34.3%). The common clinical findings were fever, cough, and cutaneous abscess. The
most common clinical syndrome was pleuropulmonary infection (44.3%), followed by
skin and soft tissue infection (22.8%). Multiorgan dissemination was found in 11.4% of
cases. The chest X-rays were abnormal in 46 cases (65.7%); alveolar and reticulonodular
infiltration was common. Only 70% had positive cultures for Nocardia spp. The resis-
tance rate of Nocardia isolates to trimethoprim-sulfamethoxazole (TMP-SMX) was very
high (57.9%) in this study. Most of the patients (85.7%)were treatedwith antimicrobials,
of which TMP-SMX was commonly used. In-hospital mortality was 20%. Most of the cases
who died had dissemination, brain abscesses or infection with TMP-SMX-resistant
strains. The long-term prognosis was good, with a treatment success rate of 93.75%.
Conclusion: Nocardiosis is a common opportunistic infection in many immunocom-
promised conditions. It can present with various clinical syndromes, especially
pleuropulmonary infection. Culture may not yield the organism but modified acid-
fast staining is very helpful in diagnosis. Drug susceptibility testing should be
performed due to increasing resistance to TMP-SMX.
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diosis.
Mean age, years 39.7  14.9
Sex distribution (male:female) 4:1
Underlying diseases No. (%)
HIV infection 24 (34.3)
Malignancya 8 (11.4)
Connective tissue diseasesb 8 (11.4)
Diabetes mellitus 4 (5.7)
Graves’ disease 1 (1.4)
Chronic lung diseasesc 3 (4.3)
Nephrotic syndrome 3 (4.3)
Infected continuous peritoneal dialysis 1 (1.4)
Autoimmune hemolytic anemia 3 (4.3)
Mitral stenosis 1 (1.4)Introduction
Nocardiosis, an infection caused by Nocardia spe-
cies, is a common opportunistic infection in immu-
nocompromised patients, especially those with
acquired immunodeficiency syndrome (AIDS) or
those using corticosteroids or immunosuppressive
agents.1—5 Although there are many reports about
nocardiosis in the literature there are few large
series from Thailand6,7 where the AIDS epidemic
continues.
This study reviews nocardiosis at Srinagarind Hos-
pital, Thailand, over a six-year period to emphasise
its importance as a common pathogen that still
causes significant morbidity and mortality.a Bronchogenic carcinoma (4), colon cancer (1), non-Hodg-
kin’s lymphoma (3).
b Dermatomyositis (1), systemic lupus erythematosus (5),
panniculitis (1), gout (1).
c Chronic obstructive lung disease (1), pulmonary alveolar
proteinosis (1), old pulmonary tuberculosis (1).Materials and methods
The medical records of patients with a diagnosis of
nocardiosis coded by the ICD-10 diagnostic coding
system at Srinagarind hospital, Khon Kaen University
teaching hospital from 1996—2001 were retrospec-
tively reviewed. Cases were included in the study if
either a clinical specimen showed positive modified
acid-fast stained filamentous bead-branching organ-
isms or a positive culture, or both. Epidemiologic
data, clinical, chest X-ray, microbiologic and treat-
ment data were collected and analysed.
Culture, identification and antimicrobial
susceptibility testing methods
The specimens from the patients were usually inocu-
lated in routine non-selective media for bacteria,
fungi and mycobacteria. Nocardia isolates were
identified and tested for antimicrobial susceptibility
using a disk diffusion method using Mueller Hilton
agar.8Table 2 Clinical presentations in 70 patients with
nocardiosis.
Clinical presentation Number of patients
(%) N = 70
Fever 48 (68.6)
Cough 42 (60)
Cutaneous abscess/ulcer 16 (22.6)
Mycetoma 2 (2.9)
Neck mass 6 (8.6)
Abdominal pain 8 (11.4)
Hemoptysis 3 (4.3)
Headache 4 (5.7)
Corneal ulcer 3 (4.3)Results
Epidemiographic data
Over the study period, there were 81 cases of
nocardiosis at Srinagarind Hospital. Eleven cases
were excluded: two cases were less than 15 years
old and the medical records of nine cases were lost.
Therefore, data of 70 cases were collected. The
age, sex distribution and underlying diseases (found
in 80% of cases) are shown in Table 1. Immunosup-
pressive agents (either corticosteroids or che-
motherapeutic agents) were concurrently used in
24.3% of cases. Only two cases with HIV infection
received antiretroviral treatment due to limitedavailability in Thailand during the study period.
The two treated patients had received dual therapy
(zidovudine plus didanosine) about one year before
developing nocardiosis.
Clinical features
The common clinical findings were fever, cough, and
cutaneous abscess (Table 2). Only 17.1% of patients
had fever less than one week before presentation.
Septic shock was documented at initial presentation
in three cases. When clinical presentations were
stratified in relation to organ involvement
(Table 3) the most common clinical syndrome was
pleuropulmonary infection (44.3%), followed by skin
and soft tissue infection (22.8%). Multiorgan disse-
mination was found in 11.4% of total cases. Brain
abscess occurred in a patient with systemic lupus
erythematosus as a result of hematogenous seeding
156 P. Mootsikapun et al.
Table 3 Clinical manifestation of 70 cases of nocardiosis.
Clinical syndrome Number of
patients (%)
Specific manifestation (number of cases)
Pleuropulmonary infection 31 (44.3) Pneumonia (25), Lung abscess (3), Empyema (3)
Skin and soft tissue infection 16 (22.9) Carbuncle (8), Cellulitis (4), Mycetoma (2),
Ulcer (1), Gluteal abscess (1)
Musculoskeletal infection 4 (5.7) Arthritis (1), Osteomyelitis (1), Pyomyositis (1),
Psoas abscess (1)
Lymphadenitis 4 (5.7)
Intraabdominal infection 4 (5.7) Peritonitis (3), Infected CAPD (1)
Eye infection 3 (4.3) Corneal ulcer (3)
Dissemination 8 (11.4) Pneumonia/gluteal abscess/pyomyositis (1),
Bacteremia (4), Pneumonia/peritonitis (1),
Pneumonia/chest wall abscess (1),
Brain abscess/pneumonia (1)from pneumonia. Bacteremia was found in four
cases, one each with mitral stenosis, diabetes mel-
litus, and AIDS and one without underlying disease.
Concurrent infections were found in eight cases,
all of whomwere AIDS patients: four with pulmonary
tuberculosis, three with cryptococcosis and one
with histoplasmosis.
The complete blood count of 44 cases was ana-
lysed; mean hemoglobin was 9.7  2.9 (range
2.5  16.2) g/dL, mean white blood cell count
13.4  0.9 (range 0.4—41.4)  109/L, and mean
polymorphonuclear cell count 78.7  15.73%. Only
one case showed pancytopenia.
Radiographic findings
Chest radiographs of all 70 cases were reviewedwith
a radiologist. They were abnormal in 46 cases
(65.7%). The abnormal findings are summarised in
Table 4. The common abnormalities were alveolar
and reticulonodular infiltration, which accountedTable 4 Chest X-ray findings.
Findings Number of patients
(%) N = 46
Alveolar infiltration 18 (39.1)
Patchy 17 (36.9)
Lobar 1 (2.2)
Interstitial infiltration 6 (13.0)
Diffuse 4 (8.7)
Perihilar 2 (4.3)
Reticulonodular infiltration 8 (17.4)
Pulmonary nodules 5 (10.7)
Pulmonary mass 4 (8.7)
Cavitary lesion 10 (21.7)
Pleural effusion 7 (15.2)
Hilar adenopathy 1 (2.2)
Pneumopyothorax 1 (2.2)
Bronchiectasis 1 (2.2)for 56.5% of cases. Cavitation and pleural effusion
were found either alone or concurrently with infil-
tration.
Microbiologic findings
All 70 patients had evidence of nocardial infection
by positive modified acid-fast staining or culture of
Nocardia spp. Forty-nine patients (70%) had posi-
tive cultures of Nocardia spp. of which 28 (40%)
cases had negative modified acid-fast staining of
the organism. Twenty-one cases had only a positive
smear as evidence of Nocardia infection but nega-
tive cultures. Seventy-eight isolates of Nocardia
were recovered from cultures of specimens, (pus
30, biopsied tissue from mycetoma 2, tissue from
bone biopsy 1, tissue from pleural biopsy 3, ascites
fluid 9, synovial fluid 3, pleural fluid 12, sputum 11,
blood 7), of which most were reported as Nocardia
spp. but ten were identified as Nocardia aster-
oides.
The susceptibility testing was carried out by the
disk diffusion method and the results are shown in
Table 5. The susceptibility rate of Nocardia spp.
isolates to trimethoprim-sulfamethoxazole (TMP-
SMX) was only 42.1%.
Treatment
Sixty cases received treatment with antimicrobials,
50 with TMP-SMX. The usual dosage of TMP-SMX used
in the treatment of nocardiosis in Srinagarind Hos-
pital was 15 mg of trimethoprim/kg/day. The other
ten cases did not receive treatment due to initially
negative modified acid-fast staining of the sputum
or pus and were referred to another hospital. Five
patients with a previous history of adverse events
from TMP-SMX were treated with other regimens;
one with azithromycin due to pancytopenia, one
each with amoxicillin/clavulanate, doxycycline plus
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Table 5 Antimicrobial susceptibilities of Nocardia iso-
lates.
Antimicrobials Number of
susceptible
isolates/total
isolates tested
(%)
Trimethoprim-sulfamethoxazole 24/57 (42.1)
Amikacin 51/53 (96.2)
Ampicillin 6/21 (28.6)
Amoxycillin/clavulanate 20/21 (95.2)
Ceftriaxone 11/15 (73.3)
Imipenem 51/52 (98.1)
Erythromycin 15/23 (65.2)cefuroxime axetil, ofloxacin, and ciprofloxacin plus
cefuroxime axetil due to allergy to TMP-SMX. There
were also five patients receiving other medications,
including two cases given amoxicillin due to amissed
diagnosis as actinomycotic mycetoma, one given
ceftriaxone plus metronidazole for peritonitis and
two given imipenem due to suspected concurrent
Gram-negative septicemia.
Outcome
Twelve cases died during admission in the hospital,
accounting for 20.0% of the 60 cases who received
treatment. Eight of these had severe pneumonia,
one had a brain abscess, and three had no initial
diagnosis. There were 18 cases lost to follow up.
Thus 32 cases were evaluated for long-term out-
come. One HIV-positive patient who had treatment
with oral doxycycline and cefuroxime axetil due to
sulfa allergy had a recurrence of Nocardia abscess of
the neck and was later lost to follow up. Another
case had mycetoma of the foot treated with amox-
icillin for three months without improvement, fol-
lowed by amputation. For the remaining 30
patients, the treatment was successful, with reso-
lution of clinical symptoms and signs as well as
pleuropulmonary abnormalities and treatment was
therefore discontinued. The median time of treat-
ment was four months (two weeks—16 months).
There were 13 cases infected with TMP-SMX-
resistant strains of Nocardia but still treated with
TMP-SMX. Data of only five cases were available, all
of whom died. The remainder were lost to follow up.Discussion
Nocardiosis is a common opportunistic infection in
immunocompromised hosts that can cause serious or
disseminated disease. More than 60% of all reportedcases of nocardiosis are associated with pre-existing
immune compromise ranging from alcoholism and
diabetes to organ transplantation and AIDS.1—6 Per-
sons requiring long-term corticosteroid treatment
are also at risk. Although the overall incidence in
AIDS is low, in this study AIDS cases comprised 34% of
the total cases or 42.8% of cases with underlying
diseases. None of the AIDS patients with nocardiosis
received TMP-SMX prophylaxis for Pneumocystis car-
inii pneumonia, either because their HIV status was
unknown or they were intolerant to sulfonamides.
This may signify the importance of TMP-SMX for
prophylaxis of opportunistic infections in HIV-posi-
tive patients.
Pulmonary disease is the predominant clinical
finding (44.3%) in this series, which is similar to
other reports.5—7 The most common pulmonary
manifestation was pneumonia but lung abscess
and empyema were also seen. No difference
between alveolar and reticulonodular or interstitial
pattern of pulmonary infiltration was found.
Although cavitation was common in pulmonary
nocardiosis (21% found in this study) no radiologic
patterns are pathognomonic.5—8
Skin and soft tissue infection was the second most
common manifestation in this study, found in 22.8%
of cases, especially cutaneous or subcutaneous
abscess. This may be explained by the fact that
themost common occupation ofmost of the patients
in the series was farming, which exposes to envir-
onmental reservoirs of Nocardia.
Disseminated infection is characterised by wide-
spread abscess formation in multiple organs includ-
ing brain, skin and soft tissue, and lung.
Disseminated nocardiosis occurred in 11.4% of cases.
Only one case had metastatic brain abscess despite
one large survey in which over 44% of systemic
nocardiosis had central nervous system involve-
ment.9 Nocardia bacteremia was reported in a min-
ority of patients with nocardiosis10 but four cases,
with one suspected endocarditis in a mitral stenosis
patient were found.
In this study, most Nocardiawere not specified. In
the literature, Nocardia asteroides is responsible for
about 80% of invasive infections whereas N. brazi-
liensis is the most frequent cause of cutaneous
disease.
Clinical experience has shown that successful
therapy requires the use of antimicrobial drug(s)
in combination with appropriate surgical drainage
or de´bridement.11 Trimethoprim-sulfamethoxazole
(TMP-SMX) is the recommended antimicrobial for
the treatment of nocardiosis although optimal anti-
microbial regimens have not been established.12
Fifty of 60 cases (83.3%) in this study who received
antimicrobials were treated with TMP-SMX.
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sion was performed in most isolates. Only 42.1% of
isolates were sensitive to TMP-SMX. There are con-
flicting opinions about the treatment of TMP-SMX
resistant nocardiosis because there is still no
accepted and validated reference and there are dis-
crepancies between in vitro data and clinical out-
come.13,14 In this series, five cases of nocardiosis
resistant to TMP-SMX did not respond to TMP-SMX
and all died. Antimicrobial susceptibility testing of
Nocardia may be indicated in patients with a lack of
response or relapse after treatmentwith TMP-SMX. In
this study, the proportion of Nocardia isolates sensi-
tive to ceftriaxone, amikacin and imipenem were
73.3%, 96.2%, and 98.1%, respectively. Clinical
experience with amikacin and imipenem has been
encouraging.15,16 Ceftriaxone-containing regimens
have been used successfully in several case reports.17
In-hospital mortality was 20% and related to
severe disease, missed diagnosis and TMP-SMX-resis-
tant strains. The long-term prognosis was good. The
success rate of treatment was 93.75%.
In conclusion, nocardiosis is not uncommon and is
still a major problem in immunocompromised hosts.
Pulmonary infection was the predominant manifes-
tation. Positive smears of Nocardia were seen in only
60% of cases, which may have resulted in missed or
delayed diagnosis in the remainder. Therefore,
nocardiosis should be suspected in immunocompro-
mised patients who are at risk.References
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